Avalanche Biotechnologies avalanchebiotech.com


Public list: BIO 2016 (619) Pharma Startups (4733)

Founded in 2006, Avalanche is a publicly traded (AAVL) biotechnology company that develops technologies and products for sustained delivery of therapeutic proteins to the eye to treat wet age-related macular degeneration (AMD), as well as other ophthalmologic disorders, such as diabetic retinopathy, retinal degeneration, and glaucoma.

Founded in 2006, Avalanche is a publicly traded (AAVL) biotechnology company that develops technologies and products for sustained delivery of therapeutic proteins to the eye to treat wet age-related macular degeneration (AMD), as well as other ophth...Show all

Company (IPO / Went public)

Phone: 650-272-6269

Fax:

1035 O'Brien Drive
Suite A
Menlo Park, 94025
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Avalanche Biotechnologies $163.3M Jul 31, 2014

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Avalanche Biotechnologies Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 9 investors

Board Members

There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Non-volatile magnetic memory element with graded layer Jul 12, 2007 Nov 22, 2011 Patent
Compositions and methods for enhanced gene expression in cone cells Mar 17, 2015 Application